Phase 1 study of LB1908, an autologous claudin 18.2-targeted CAR-T cell product, in subjects with advanced gastroesophageal adenocarcinoma.

Detalles Bibliográficos
Publicado en:Journal of Clinical Oncology Vol. 44; pp. 374 - 561
Autores principales: Zhen, David Bing, Maziarz, Richard T., Chen, Emerson Yu-sheng, Fountzilas, Christos, Kim, Dae Won, Gutierrez, Martin, Gibson, Michael K., DeVito, Nicholas C., Phan, Alexandria T., Oshrine, Benjamin, Koneru, Mythili, Vahora, Sahista, Wang, Chuan, Xin, Lijun, Davis, Christian, Zhang, Jinghui, Shields, Anthony F.
Formato: Journal Article
Publicado: American Society of Clinical Oncology 2026 Supplsmsnr 2
Acceso en línea:Ver este registro en EBSCOhost